Edition:
United Kingdom

Pieris Pharmaceuticals Inc (PIRS.OQ)

PIRS.OQ on NASDAQ Stock Exchange Capital Market

5.20USD
19 Oct 2018
Change (% chg)

$-0.10 (-1.89%)
Prev Close
$5.30
Open
$5.29
Day's High
$5.42
Day's Low
$5.12
Volume
67,007
Avg. Vol
117,929
52-wk High
$9.69
52-wk Low
$4.44

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 11.69 -0.004
Mar '18 4.15 -0.174
FY 2017 Dec '17 18.15 0.167
Sep '17 3.93 -0.159
Jun '17 1.85 -0.232
Mar '17 1.34 -0.186
FY 2016 Dec '16 2.73 -0.152
Sep '16 0.79 -0.144
Jun '16 1.07 -0.144
Mar '16 1.25 -0.104
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 5 7.51 13.40 4.60 0.00
Quarter Ending Mar-19 1 5.80 5.80 5.80 --
Year Ending Dec-18 5 30.74 41.60 24.80 4.67
Year Ending Dec-19 5 22.57 31.00 12.00 3.10
Earnings (per share)
Quarter Ending Dec-18 5 -0.12 -0.03 -0.17 -0.21
Quarter Ending Mar-19 1 -0.20 -0.20 -0.20 --
Year Ending Dec-18 5 -0.46 -0.23 -0.56 -0.85
Year Ending Dec-19 5 -0.75 -0.63 -0.95 -0.95
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.41 33.64
P/E High - Last 5 Yrs. -- 287.36 45.19
P/E Low - Last 5 Yrs. -- 89.75 23.75
Beta -- 0.93 0.88
Price to Sales (TTM) 41.16 124.37 5.83
Price to Book (MRQ) 29.26 15.29 4.89
Price to Tangible Book (MRQ) 29.57 14.52 6.51
Price to Cash Flow (TTM) -- 70.10 22.92
% Owned Institutions 50.96 14.25 2.14

Dividends

  Company industry sector
Dividend Yield -- 0.33 1.51
Dividend Yield - 5 Year Avg -- 0.24 1.52
Dividend 5 Year Growth Rate -- 2.54 5.40
Payout Ratio(TTM) -- 16.75 43.85

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 72.70 411.57 8.10
Sales (TTM) vs TTM 1 Yr. Ago 37.63 103.65 5.80
Sales - 5 Yr. Growth Rate -- 30.74 9.87
EPS (MRQ) vs Qtr. 1 Yr. Ago -61.36 24.06 23.38
EPS (TTM) vs TTM 1 Yr. Ago -69.16 -- --
EPS - 5 Yr. Growth Rate -- 37.62 10.92
Capital Spending - 5 Yr. Growth Rate -- 38.52 14.87

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.95 2.25
Current Ratio (MRQ) 2.87 5.36 3.05
LT Debt to Equity (MRQ) 0.00 34.93 12.76
Total Debt to Equity (MRQ) 0.00 36.74 17.18
Interest Coverage (TTM) -92.13 -96.75 37.50

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.09 54.87
Gross Margin - 5 Yr. Avg. -- 49.02 52.39
EBITD Margin (TTM) -417.27 -- --
EBITD - 5 Yr. Avg -- -579.09 11.01
Operating Margin (TTM) -424.61 -786.66 4.07
Operating Margin - 5 Yr. Avg. -- -600.20 6.34
Pre-Tax Margin (TTM) -445.15 -748.77 5.12
Pre-Tax Margin - 5 Yr. Avg. -- -605.79 6.78
Net Profit Margin (TTM) -459.70 -749.75 1.39
Net Profit Margin - 5 Yr. Avg. -- -608.47 3.03
Effective Tax Rate (TTM) -- 23.52 23.24
Effective Tax Rate - 5 Yr. Avg. -- 18.69 24.16

Efficiency

  Company industry sector
Revenue/Employee (TTM) 136,884 22,677,535 808,218,600
Net Income/Employee (TTM) -629,254 1,703,754 95,058,584
Receivable Turnover (TTM) -- 20.77 5.78
Inventory Turnover (TTM) -- 2.37 3.63
Asset Turnover (TTM) 0.09 0.40 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -40.46 -1.39 10.90
Return on Assets - 5 Yr. Avg. -- 3.03 12.01
Return on Investment (TTM) -55.96 0.21 14.27
Return on Investment - 5 Yr. Avg. -- 2.10 15.60
Return on Equity (TTM) -132.26 1.17 15.99
Return on Equity - 5 Yr. Avg. -- 2.74 16.87
  1 Year 3 Year 5 Year
Sales % 98.87 -22.30 --
EPS (TTM) % -33.71 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Pieris Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 65.60%
# of Holders: 146
Total Shares Held: 35,448,273
3 Mo. Net Change: -417,511
# New Positions: 1
# Closed Positions: 2
# Increased Positions: 8
# Reduced Positions: 8
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.